Faculty of Pharmacy, Chiang Mai University, Chiang Mai 50200, Thailand.
J Biomed Nanotechnol. 2011 Jun;7(3):366-76. doi: 10.1166/jbn.2011.1300.
This study has demonstrated the enhancement of cellular uptake of GFP when fused with Tat (Tat-GFP) and loaded in elastic niosomes. GFP and the GFP fused with Tat at C- and N-terminals were expressed in E. coli BL21 (DE3). The N-terminal Tat-GFP fusion protein (Tat-GFP) which showed the highest uptake of 5.2% in HT-29 cell line at 2.4 folds of GFP was selected to load in various charged non-elastic and elastic niosomes and liposomes. All niosomes showed higher entrapment efficiency (EE) of the fusion protein more than in liposomes with the highest EE of 100% in elastic cationic niosomes. However, the fusion protein loaded in elastic anionic niosomes (Tween 61/cholesterol/dicetyl phosphate at 1:1:0.05 molar ratio) which gave the EE of only 32.8% showed the highest cellular uptake of GFP at 6.7, 2.8 and 1.7 times of GFP, Tat-GFP and Tat-GFP loaded in elastic cationic niosomes, respectively. After the 3 month-storage at 30 +/- 2 degrees C, the percentages remaining of the fusion protein loaded in the elastic anionic niosomes (61.9 +/- 12.7%) were about 2 times higher than the non-loaded fusion protein (33.7 +/- 2.8%). Thus, the cellular uptake and the chemical stability of the fusion protein were enhanced when loaded in elastic niosomes, especially the elastic anionic niosomes which can be further developed as an efficient delivery system for many therapeutic proteins.
本研究表明,与 Tat(Tat-GFP)融合并装载在弹性脂囊中时,GFP 的细胞摄取得到增强。GFP 和 GFP 在 C 端和 N 端与 Tat 融合在大肠杆菌 BL21(DE3)中表达。选择摄取率最高的 N 端 Tat-GFP 融合蛋白(Tat-GFP)(在 HT-29 细胞系中为 GFP 的 2.4 倍,摄取率为 5.2%)装载在各种带电荷的非弹性和弹性脂囊和脂质体中。所有脂囊均显示出比脂质体更高的融合蛋白包封效率(EE),其中弹性阳离子脂囊的 EE 最高可达 100%。然而,装载在弹性阴离子脂囊(Tween 61/胆固醇/二硬脂酸磷酸酯摩尔比为 1:1:0.05)中的融合蛋白 EE 仅为 32.8%,其 GFP 的细胞摄取率分别为 GFP、Tat-GFP 和装载在弹性阳离子脂囊中的 Tat-GFP 的 6.7、2.8 和 1.7 倍。在 30 +/- 2 摄氏度下储存 3 个月后,装载在弹性阴离子脂囊中的融合蛋白(61.9 +/- 12.7%)的剩余百分比约为未装载融合蛋白(33.7 +/- 2.8%)的 2 倍。因此,当装载在弹性脂囊中时,融合蛋白的细胞摄取和化学稳定性得到增强,特别是弹性阴离子脂囊,可进一步开发为许多治疗性蛋白质的有效递送系统。